SEARCH
NASDAQ: UNCY Unicycive’s Doug Jermasek, EVP-Corporate Development Talks Medication Compliance
Benzinga
2022-11-07
Views
1
Description
Share / Embed
Download This Video
Report
Unicycive Therapeutics, Inc. is a biotechnology company dedicated to developing treatments for certain medical conditions. The Company is focused on identifying medical conditions within and outside of kidney disease.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x8fanc5" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
00:35
Super Micro Computer Receives Compliance Warning From Nasdaq As It Files Compliance Plan, Brings On A New Auditor
08:09
NASDAQ: $UNCY Pivotal For The People: An Exciting Clinical Trial & An Interview With UNCY's EVP!
01:41
Former Universal EVP Doug Neil Named Marketing Brand Chief At NFT
03:47
Focus on our new CSR program with Caroline Le Masne de Chermont, EVP, Legal affairs, Compliance and CSR, Vivendi Group
02:58
EVP Corporate Communication & CSR BCA, Hera F. Haryn Raih Penghargaan Puspa Bangsa Kategori Adidaya
00:44
SMCI’s Rollercoaster Year: Rapid Growth, Allegations, And NASDAQ Compliance Struggles
00:31
Super Micro Regains Nasdaq Compliance After Filing Delayed Financials. Shares Surge 22%
00:44
Super Micro Shares Jump 37% After Naming New Auditor Amid Nasdaq Compliance Efforts
03:07
WWE Taps DAZN’s Jamie Horowitz As EVP Development & Digital Expanding | Moon TV News
04:19
Getting Doug With High's Doug Benson Talks About His Weirdest Cannabis Moments
41:53
Texans EVP & GM Nick Caserio talks Stroud's Improvement & More
01:20
Evince Development Corporate Presentation - Web Design and Development, Mobile App Development